ANIXA BIOSCIENCES INC
ANIX·03528H109·US·Common Stock·Healthcare - Biotechnology-Activist
ANIX (ANIXA BIOSCIENCES INC) is held by 38 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($3.4M), UBS Group AG ($1.4M), D.A. DAVIDSON & CO. ($1.4M). Net institutional sentiment: Mixed.
38
Holders
Avg rating(11 Elite)
$10.8M
Total Value
49% (49)
Fund Consensus
17 buying - 18 selling
Who's Trading
InsiderKAKUMAR AMITBuy $15KJul 10, 2026
InsiderTJTitterton Lewis H jrBuy $7KJun 16, 2026
InsiderKAKUMAR AMITBuy $53KJun 12, 2026
InsiderBMBaskies Arnold MBuy $30KJan 28, 2026
ActivistMCMichael Catelani7.0%Jan 6, 2026
InsiderKAKUMAR AMITBuy $16KJul 30, 2025
InsiderBMBaskies Arnold MBuy $17KJul 18, 2025
InsiderTJTitterton Lewis H jrBuy $31KJul 11, 2025
InsiderKAKUMAR AMITBuy $16KJul 11, 2025
ActivistAKAmit Kumar16.3%Jun 6, 2025
13F: Insider & Congress:
Showing 1-20 of 49
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer